$ARIA News Ariad takes another pounding after leukemia

New Post Public Reply Private Reply Replies (0) Message Board

Nov 21, 2013 at 6:29 PM

$ARIA News

Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Don't be a fan when investing 8:26 a.m. Dec. 20, 2011 - The Trading Deck
Drug stocks move higher in late trading 2:26 p.m. March 24, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:12 p.m. Jan. 18, 2011 - Kate Gibson
Ariad soars as drug indexes move higher 12:47 p.m. Jan. 18, 2011 - Val Brickates Kennedy
Ariad rallies as drug indexes modestly rise 10:23 a.m. Jan. 18, 2011 - Val Brickates Kennedy
Aria rockets on cancer drug data 9:38 a.m. Jan. 18, 2011 - Val Brickates Kennedy
Ariad jumps on leukemia drug data 3:46 p.m. Dec. 6, 2010 - Val Brickates Kennedy

2 Pharmas That Should Move After 55th ASH Meeting 10:39 a.m. Nov. 20, 2013 - Seeking Alpha
9 Biotechnology Stocks to Buy Now 6:45 a.m. Nov. 20, 2013 - InvestorPlace.com
Ariad Pharmaceuticals, Inc. Enters Oversold Territory - Tale of the Tape 8:46 a.m. Nov. 18, 2013 - Zacks.com
Benzinga's Top #PreMarket Gainers 7:10 a.m. Nov. 18, 2013 - benzinga.com
7 Biotechnology Stocks to Buy Now 5:00 a.m. Nov. 13, 2013 - InvestorPlace.com
10-Q: ARIAD PHARMACEUTICALS INC 4:36 p.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
Ariad Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript 2:30 p.m. Nov. 12, 2013 - Seeking Alpha
Sirius XM Will Host Baseball Giant Joe Torre and 2 Other Hot Stocks to Watch 12:14 p.m. Nov. 12, 2013 - Wall St. Cheat Sheet
ARIAD Pharmaceuticals, Inc. Discusses Q3 2013 Results (Webcast) 8:25 a.m. Nov. 12, 2013 - Seeking Alpha
Health-Care Stocks: Where to Find Value 6:07 a.m. Nov. 12, 2013 - Barrons.com
JPMorgan Considers Ban on Trader Chat Rooms and 2 Other Hot Stocks to Watch 12:17 p.m. Nov. 11, 2013 - Wall St. Cheat Sheet
Benzinga's Top #PreMarket Gainers 7:13 a.m. Nov. 11, 2013 - benzinga.com
Shire, Novartis Deals: Pharmaceutical Shakeups Continue 6:55 a.m. Nov. 11, 2013 - 247WallSt.com
EMA's PRAC Updates On The Risks Of Serious Vascular Occlusive Events Associated With Cancer Medicine Iclusig 8:37 a.m. Nov. 8, 2013 - benzinga.com
ARIAD Shares Tumble on Iclusig Woes - Analyst Blog 5:20 p.m. Nov. 7, 2013 - Zacks.com
ARIAD to Cut 40% of US Staff Positions 3:18 p.m. Nov. 7, 2013 - benzinga.com
Ariad Pharmaceuticals (ARIA) Marked As A Dead Cat Bounce Stock 9:45 a.m. Nov. 6, 2013 - TheStreet.com
6 Biotechnology Stocks to Buy Now 5:15 a.m. Nov. 6, 2013 - InvestorPlace.com
Canada Said to Have Blocked BlackBerry Takeover and 2 More Heavily Traded Stocks to Follow 4:59 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
The Drive Behind Ariad Pharmaceuticals' (ARIA) Partial Recovery 1:51 p.m. Nov. 4, 2013 - TheStreet.com

Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals 8:00 a.m. Nov. 20, 2013 - PR Newswire
Must Watch News & Earnings: Tesla Motors Inc, Pan Global Corp, Ariad Pharmaceuticals, Alpha Natural Resources, Brocade Communications Systems 10:23 a.m. Nov. 19, 2013 - PR Newswire
Appointments, Financial Results, Divestitures, and Staff Reductions- Research Report on AstraZeneca, VIVUS, Cooper, ARIAD, and Amarin 8:00 a.m. Nov. 13, 2013 - PR Newswire
Stock Analysis Reports on AMD, ARIA and GSAT 1:20 a.m. Nov. 13, 2013 - ACCESSWIRE
ARIA, DNDN, HSOL and OREX added to NASDAQ Active Stock Watch List at EPR 9:29 a.m. Nov. 12, 2013 - ACCESSWIRE
Shareholder Rights Law Firm Johnson & Weaver, LLP Files Derivative Lawsuit on behalf of ARIAD Pharmaceuticals, Inc. 9:29 a.m. Nov. 12, 2013 - BusinessWire
ARIAD Reports Third Quarter 2013 Financial Results and Announces Significant Expense Reduction 7:35 a.m. Nov. 12, 2013 - BusinessWire
Glancy Binkow & Goldberg Announces a December 9, 2013 Lead Plaintiff Deadline in the Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. - ARIA 9:10 a.m. Nov. 11, 2013 - GlobeNewswire
News and Updates on ARIA, AFYG and ASAB 1:27 a.m. Nov. 8, 2013 - ACCESSWIRE
ARIAD Announces Reduction in U.S. Workforce as Part of Broad Program to Reduce Operating Expenses 4:05 p.m. Nov. 7, 2013 - BusinessWire
Financial Results and Upcoming Conference Calls - Research Report on Ariad, Idenix, Osiris, InterMune, and Array BioPharma 8:00 a.m. Nov. 6, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of Ariad Pharmaceuticals, Inc. 8:10 p.m. Nov. 5, 2013 - PR Newswire
Top Trial Firm Cohen, Placitella & Roth, PC Investigating Ariad Pharmaceuticals, Inc., for Suspending Sales of its Leukemia Drug Iclusig 12:50 p.m. Nov. 5, 2013 - PR Newswire
Stock Price Movement Update, Recognitions, and Financial Results - Research Report on Ariad Pharmaceuticals, Quintiles, Molina Healthcare, Exelixis, and Masimo 8:00 a.m. Nov. 4, 2013 - PR Newswire
Today's Equity Reports on BZNE, ARIA, AXPW and SPDL 2:25 a.m. Nov. 4, 2013 - ACCESSWIRE
Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. 9:32 p.m. Nov. 1, 2013 - BusinessWire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 1:30 p.m. Nov. 1, 2013 - PR Newswire
ARIAD Adopts Shareholder Rights Plan to Preserve Valuable Net Operating Loss Carryforwards and Other Tax Benefits 8:35 a.m. Nov. 1, 2013 - BusinessWire
ARIAD Announces Change to the Date of Its Third Quarter 2013 Financial Results Conference Call and Webcast to November 12, 2013 4:30 p.m. Oct. 31, 2013 - BusinessWire
ARIAD Announces Temporary Suspension of Iclusig Marketing in the United States 7:30 a.m. Oct. 31, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CSG Powers Midwest Electrification, Eyes Energy Bridge

Every now and again, a player like China Southern Power Grid steps up, making waves in the vast energy sea of the Asia-Pacific. The power company's latest foray, showcased at the Asia-Pacific Media Forum in Shenzhen, underscores its ambitions to beef up regional energy connectivity. Asia-Pacific's Hungry Energy Machine The Asia-Pacific region is no lightweight when it...

Early Orders Key for Custom Kids' Gifts This Season

Unwrap the Secret to Perfect Holiday Presents When it comes to giving the little ones something special for the holidays, the trick lies in timing. Not your run-of-the-mill timing, mind you—I'm talking about understanding how handcrafted, personalized toys can make or break the season. If you've ever scrambled for a last-minute gift, you know how that shaky feeling sets...

Dentsply Sirona Faces Insider Troubles: An Investor Call

Are Dentsply Sirona Insiders on Thin Ice? The stock market's a tumultuous sea, and right now, it seems like some of those at the helm of Dentsply Sirona Inc. might be rocking the boat a bit too much. Let me tell you, navigating these corporate storms isn't for the faint-hearted. The latest noise coming from Halper Sadeh LLC suggests that some directors and officers over...

Drunk Angel Celebrates First Year in Crystal Jewelry

One Year Down, A Unique Path Forward It's been a year since Drunk Angel jumped into the online jewelry scene, and they're setting themselves apart in their own glittery lane. Imagine starting a brand that's not just about pretty trinkets, but about linking those tiny treasures to timeless traditions. They've got their sights set on blending the deep tales of gemstones...

How Timekettle Is Bridging Language Gaps at IFA 2026

Pioneering AI Innovations in Language Translation Timekettle is making some serious waves at IFA 2026, throwing its hat in the ring with innovations that redefine multilingual interaction. From sleek translation earbuds to full-blown meeting hubs, each gadget screams one thing loud and clear—communication sans language barriers. Centered in the tech extravaganza of...

Indiana Fire Safety: The Importance of Regular Inspections

Everybody thinks of fire extinguishers as those red cans hanging quietly on walls, but there's more to them than meets the eye. In Central Indiana, these devices are a literal lifeline, and neglecting their upkeep is playing with fire—literally. What Makes Monthly Checks a Big Deal? Fire extinguishers aren't just there for decoration. They're critical safety gear. This...

1M+ California Homes Face Extreme Wildfire Risk Revealed

Wildfire Risk in California: A Growing Alarm If there's one thing that's become a bitter truth over the years, it's that California and wildfires are inseparably linked, like mayo on a greasy diner BLT—except way worse for the gut. The latest round of data from Guidewire HazardHub is practically sounding the alarm bells louder than ever. Over a million homes in...

Innventure Faces Major Lawsuit Amidst Market Turmoil

The Plot Thickens with Innventure's DarkNX Project Buckle up, fellow market sling-riders; the Innventure tale is a rocky one for the books. Imagine this: You’ve plunked down your hard-earned cash on Innventure Inc. (NASDAQ: INV), lured by their glowing pronouncements about a supposed golden egg project, the Accelsius DarkNX data-center deal. A big talk about...

BrightPlan's AI-Powered Growth: Series C Fuel

Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...

Big Wins at Americas Cardroom's $15M Venom Series

High Stakes and Huge Paydays: The Venom Breakdown Alright, folks, here's a tale of how the cards fell in one of the most electrifying poker standoffs at Americas Cardroom. With prize pools clocking in at a staggering $15.095 million, the Dual Mystery Bounty Venoms really stacked the chips high. From the gritty, bustling halls of the internet to the proverbial green-felt...